1.
Ledoult E, Groh M, Meresse B, Dubois R, Trauet J, Toussaint E, Delbeke M, Hachulla E, Terriou L, De Masson A, Vasseur M, Labalette M, Launay D, Kahn J-E, Lefevre G. Targeting CCR4 with mogamulizumab in refractory CD3<sup>-</sup>CD4<sup>+</sup&gt; lymphocytic-variant hypereosinophilic syndrome. haematol [Internet]. 2024Jun.1 [cited 2024Jun.13];109(6):1984-8. Available from: https://haematologica.org/article/view/haematol.2023.284429